Quent Capital, LLC Ab Cellera Biologics Inc. Transaction History

Quent Capital, LLC

  • $950 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jun 14, 2024
BUY
$7.31 - $11.18 $203,656 - $311,474
27,860 New
27,860 $210,000
Q3 2022

Nov 10, 2022
BUY
$9.2 - $13.68 $30,451 - $45,280
3,310 Added 13.48%
27,860 $276,000
Q1 2022

May 12, 2022
BUY
$7.46 - $14.14 $26,110 - $49,490
3,500 Added 16.63%
24,550 $239,000
Q4 2021

May 12, 2022
BUY
$12.99 - $17.73 $273,439 - $373,216
21,050 New
21,050 $301,000

Others Institutions Holding ABCL

# of Institutions
153
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $787M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email